Drying and granule formation in only ONE process step. Benefit from Glatt spouted bed and fluid bed technology. Visit us at Food and Nutritional Ingredients from May 25-27, 2022 at the Istanbul Expo Center. You will find the Glatt experts for particle design, process technology and plant engineering in hall 10 at booth D201.
When running processes such as fluid bed and spouted bed drying, granulation, encapsulation and coating, which production management is most advantageous for contract manufacturers: continuous or batch mode? Gudrun Ding, Head of Business Development, Process Technology, Glatt Ingenieurtechnik provides an insight into their everyday practices and points out which mode of operation offers most benefits. Glatt + Erbo Spraytec provide an insight into practice
In his lecture on “Fluid bed granulation/coating – equipment design and operations”, Didier Schons, Glatt Ingenieurtechnik, will explain these topics, presenting the differences between batchwise and continuous operation, as well as various aspects for particle and product flow. You will learn more about open and closed process gas systems as well as about the premises for the use of multi-purpose plants. The explanations will be illustrated by means of selected case studies.
Find out more about how Glatt, as a plant manufacturer and expert in technologies and processes for particle design, is meeting the current requirements from the powder processing industry. In their presentation “Trends and challenges in fluid bed encapsulation processes”, Katja Oppermann and Didier Schons, both Glatt Ingenieurtechnik, will explain which options are opened up by adapted technological concepts.
Free-flowing granules and pellets from liquids and powders using innovative fluid bed and spouted bed technology at Booth G12 in Hall 1. With state-of-the-art fluid bed and spouted bed technologies, Glatt offers intelligent particle design to dry, shape and functionalize powders and granules with the desired properties in just one process step, improving their application and handling.
On 1 March 2022, Glatt Ingenieurtechnik GmbH opened a new branch in Cologne. The new unit will showcase the company’s pharmaceutical, biotechnology and active ingredient plant expertise and represents Glatt’s first location in North Rhine-Westphalia. The decision to expand was based on a positive market outlook in the field of pharmaceutical engineering and excellent capacity utilization.
In January 2022, plant manufacturer and process expert, Glatt Ingenieurtechnik, expanded its powder synthesis capacity at the company’s technology center in Weimar. The newly installed system ensures a homogenous process temperature throughout the entire length of the ProAPP® 80 HT reactor or the targeted adjustment of temperature gradients. This allows different process steps to be combined.
Weimar, Germany, March 2022: Glatt Ingenieurtechnik GmbH (Weimar, Germany) will be responsible for the Basic Engineering of the process technology for the multipurpose BioCampus MultiPilot (BMP) plant on behalf of BioCampus Straubing GmbH. Here, at the Straubing-Sand port, customers will be able to develop, test, optimize and scale-up industrial biotechnology processes, validate their economic viability and manufacture samples.
SaMBa research project for a novel fabrication process for high permeability oxygen membranes and development of an innovative membrane connection plate for oxygen generators: “Mixed ionic electronic conductor” (MIEC) Membranes are specialized single phase materials which exhibit significant electron and ionic conductivity. Neutral molecules can be transported through a solid membrane and separated from other components. BSCF (barium-strontium-cobalt-iron oxide) enables oxygen exchange. Research focuses on the production of BSCF by Glatt powder synthesis and the subsequent production of the membranes for oxygen separation from air.
Elaboration of the plant and control engineering fundamentals for the precise control of particle growth in granulation processes. From this, reliable statements on the industrial scalability and pharmaceutical suitability of self-regulating granulation processes can be derived. The results create the technological prerequisites for a completely new quality level in the manufacture of pharmaceutical products (granules and tablets).
Copyright by Glatt
Copyright by Glatt